Platform overview

AtKaralis-AIwe deliver modular, in silico solutions designed to support pharmaceutical and biotech partners working on new antiinfectives—especially for Gram-negative targets.

NOD2 protein

Our technology blends mechanistic insight, AI-driven prediction, and experimental validation.

Mechanistic Screening & Prediction Tools

Antimicrobial Peptide (AMP) Design​

AI-Driven Property Prediction​

Integrated Experimental Validation​

How we help

Precision tools forbiotech and pharma— built for strategic investors

For Pharma and Biotech

For Investors

AI screening
Mechanistic filters
Trojan-horse antibiotics
Siderophore uptake
Antibiotic modeling
Peptide delivery
Drug discovery
AMR
Pretrained models
Peptides
Proprietary tech

Empower innovation in antimicrobialresearch

Let’s discuss how we can power your next discovery project